WW International Reports Q3 2026 Results Driven by Clinical Subscription Growth
WW International (WW) reported third-quarter revenue of $152.9 million, an 11% decrease year-over-year due to a shrinking Core subscriber base. However, the company is successfully pivoting toward higher-value offerings; clinical subscription revenue surged 48% to $38 million, now accounting for 25% of total revenue. This shift is reflected in a 14% increase in monthly subscription ARPU to $21.17. Profitability metrics showed significant improvement, with Adjusted EBITDA reaching $51.7 million and an Adjusted Gross Margin of 74.6%, the highest level seen in 2026. The company also achieved its second consecutive quarter of positive net income following its reorganization. Management has narrowed full-year revenue guidance to a range of $625 million to $630 million, signaling confidence in their current margin expansion and debt reduction strategies.
Topics: clinical subscription growth profitability revenue decline subscriber metrics
Read the full article at Motley Fool
Part of the story Crane NXT Reports Q3 2026 Results with Growth Driven by Antares Vision Acquisition (10 articles)